IQV IQVIA Holdings, Inc. Common Stock
$256,14
Kurs · Aug 21, 2026
Fundamentaldaten per Jul 28, 2026
52W-Spanne
$154–$260
96% of range
Analystenbewertung
BUY
28 analysts
Kursziel
$275
+7% upside
P/E (TTM)
50.0
ROE
21.6%
Nettogewinnmarge
8.3%
Über IQVIA Holdings, Inc. Common Stock Unternehmensübersicht von Wikipedia
IQVIA ist ein US-amerikanisches Unternehmen im Bereich der Gesundheitsforschung und -datenanalyse. Das Unternehmen entstand 2016 durch die Fusion des Auftragsforschungsinstituts Quintiles und des Marktforschungsunternehmens IMS Health. IQVIA bietet Dienstleistungen für Unternehmen der Life-Science- und Gesundheitsbranche an und beschäftigt weltweit über 80.000 Mitarbeiter in mehr als 100 Ländern. Es gehört zu den größten Auftragsforschungsinstituten weltweit.
Mehr lesen
IQVIA (bis 2017 QuintilesIMS) ist ein US-amerikanisches Unternehmen im Bereich der Gesundheitsforschung und -datenanalyse. Das Unternehmen entstand 2016 durch die Fusion des Auftragsforschungsinstituts Quintiles und des Marktforschungsunternehmens IMS Health. IQVIA bietet Dienstleistungen für Unternehmen der Life-Science- und Gesundheitsbranche an und beschäftigt weltweit über 80.000 Mitarbeiter in mehr als 100 Ländern. Es gehört zu den größten Auftragsforschungsinstituten (Contract Research Organizations, CRO) weltweit.
Geschichte
Quintiles wurde 1982 von Dennis Gillings in den USA gegründet und spezialisierte sich auf die Organisation und Durchführung klinischer Studien für Pharma- und Biotech-Unternehmen. IMS Health geht auf eine Gründung im Jahr 1954 zurück und entwickelte sich zu einem führenden Anbieter von Gesundheitsdaten und pharmazeutischer Marktforschung. Beide Unternehmen wuchsen über Jahrzehnte in ihren Branchen: Quintiles galt als weltweit führend bei klinischen Auftragsstudien und hatte 2014 einen weltweiten Marktanteil von 15 %, während IMS Health große Datenbestände über Arzneimittelverkäufe und Versorgungsdaten aufbaute. Quintiles wurde 1997 zu einem börsennotierten Unternehmen und führte 2013 eine erfolgreiche Sekundäraktienemission durch. IMS Health ging 2014 an die Börse.
Im Oktober 2016 fusionierten Quintiles und IMS Health zu einem gemeinsamen Konzern namens QuintilesIMS. Durch den Zusammenschluss wurden die Kompetenzen beider Unternehmen – klinische Forschung und Gesundheitsdaten-Analytik – unter einem Dach vereint. Im November 2017 gab das Unternehmen die Umbenennung in IQVIA bekannt. Der neue Name setzt sich aus den Anfangsbuchstaben „I“ (für IMS Health) und „Q“ (für Quintiles) sowie dem lateinischen Wort „via“ für Weg zusammen, als Anspielung auf die Entstehung des Unternehmens aus den beiden Vorgängern. Seit der Fusion hat IQVIA sein Geschäft weiter ausgebaut und ist an der New York Stock Exchange unter dem Kürzel IQV notiert.
Tätigkeit
IQVIA ist in verschiedenen Bereichen der Gesundheitswirtschaft aktiv. Das Unternehmen unterstützt Pharma- und Biotechnologieunternehmen sowie staatliche Gesundheitseinrichtungen und Kostenträger mit Dienstleistungen entlang des gesamten Medikamentenlebenszyklus. Zu den zentralen Geschäftsfeldern gehören die Planung und Durchführung klinischer Studien (Phasen I–IV) für neue Medikamente im Auftrag Dritter, die Erhebung und Auswertung von Gesundheitsdaten (etwa zu Arzneimittelverordnungen und Therapieergebnissen) sowie Beratungs- und Technologielösungen für Akteure im Gesundheitswesen. IQVIA stellt beispielsweise großen Pharmakonzernen Datenanalysen zur Verfügung, um bei Zulassungsstudien, Markteinführungen und der Überwachung von Arzneimittelsicherheit zu unterstützen. Zudem entwickelt das Unternehmen Software und Plattformen, die den Austausch und die Analyse von medizinischen Daten erleichtern.
Ein bedeutender Teil der Tätigkeit von IQVIA liegt in der Nutzung umfangreicher Gesundheitsdaten. Die früheren IMS-Datenbanken verfolgten nach Unternehmensangaben zeitweise über eine Million Arzneimittelprodukte und erfassten rund 80 % der weltweiten Arzneimittel-Verkaufstransaktionen anonymisiert. Die Kombination aus Datenmaterial und eigener Forschungskapazität verschafft dem Unternehmen eine große Marktmacht.
Kontroversen
Die großen Datensammlungen von ISM Health sorgten sowohl in Deutschland als auch in den USA für Bedenken hinsichtlich Privatsphäre und Datenschutz von Patienten.
Am 17. Juli 2023 klagte die Federal Trade Commission (FTC) gegen die Übernahme von Propel Media durch IQVIA und behauptete in einer Verwaltungsklage, dass die Übernahme IQVIA eine marktführende Position im Bereich der programmatischen Werbung im Gesundheitswesen verschaffen und die Preise für die Verbraucher im Gesundheitswesen erhöhen würde. Dadurch scheiterte die geplante Übernahme.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
IQV Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$256.13
Marktkapitalisierung
$66.49B
P/E (TTM)
50.0
EPS (TTM)
$7.84
Umsatz (TTM)
$16.31B
Dividendenrendite
—
ROE
21.6%
Verschuldungsgrad
2.4
52W-Spanne
$155 – $260
IQV Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$16.31B
2016-12-31
→
2025-12-31
EPS
$7.84
2016-12-31
→
2025-12-31
Freier Cashflow
$2.05B
2016-12-31
→
2025-12-31
Margen
8.3%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
IQV
Peer-Median
P/E (TTM)
50.0
35.2
P/S (TTM) (K/V (TTM))
4.1
5.8
P/B (K/B)
10.2
6.2
EV / EBITDA
24.1
—
Price / FCF (Kurs / FCF)
32.4
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
IQV
Peer-Median
Operating Margin (Betriebsgewinnmarge)
13.4%
—
Net Profit Margin (Nettogewinnmarge)
8.3%
16.1%
ROA
4.8%
8.4%
ROE
21.6%
19.1%
ROIC
8.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
IQV
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
2.4
—
Current Ratio (Liquiditätsgrad)
0.7
1.7
Quick Ratio
0.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
IQV
Peer-Median
Revenue YoY (Umsatz YoY)
5.9%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
4.2%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
7.5%
—
EPS YoY (EPS VjV)
4.7%
—
Net Income YoY (Nettogewinn YoY)
-0.95%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
IQV
Peer-Median
IQV Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
28 Analysten
- Starker Kauf 8 28,6%
- Kauf 14 50,0%
- Halten 6 21,4%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
18 Analysten · 2026-08-17
Median
$278.00
Jetzt
$256.13
Tief
$240.00
Hoch
$300.00
Median-Ziel
$278.00
+8,5%
Mittelwert-Ziel
$275.17
+7,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.03%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $3.15 | $3.06 | 0.09% |
| 31. März 2026 | $2.90 | $2.85 | 0.05% |
| 31. Dezember 2025 | $3.42 | $3.43 | -0.01% |
| 30. September 2025 | $3.00 | $3.00 | -0.00% |
| 30. Juni 2025 | $2.81 | $2.80 | 0.01% |
| 31. März 2025 | $2.70 | $2.66 | 0.04% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.31B | $15.40B | $14.98B | $14.41B | $13.87B | $11.36B | $11.09B | $10.41B | $9.70B | $6.82B | $5.74B | $5.46B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $4.62B | $3.24B | $2.71B | $2.66B | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | $3M | $6M | |
| SG&A Expense | $2.00B | $1.99B | $2.05B | $2.07B | $1.96B | $1.79B | $1.73B | $1.72B | $1.62B | $1.02B | $815M | $781M | |
| Operating Income | $2.18B | $2.20B | $1.98B | $1.80B | $1.39B | $731M | $777M | $741M | $665M | $576M | $646M | $590M | |
| Interest Expense | $729M | $670M | $672M | $416M | $375M | $416M | $447M | $414M | $346M | $144M | $101M | $101M | |
| Interest Income | $45M | $47M | $36M | $13M | $6M | $6M | $9M | $8M | $7M | $4M | $4M | $4M | |
| Other Non-op | $99M | $90M | $124M | $-33M | $130M | $65M | $37M | $-5M | $-13M | $11M | $-2M | $8M | |
| Pretax Income | $1.59B | $1.67B | $1.46B | $1.36B | $1.13B | $373M | $352M | $328M | $294M | $416M | $539M | $501M | |
| Income Tax | $252M | $301M | $101M | $260M | $163M | $72M | $116M | $59M | $-992M | $325M | $159M | $149M | |
| Net Income | $1.36B | $1.37B | $1.36B | $1.09B | $966M | $279M | $191M | $259M | $1.28B | $72M | $387M | $357M | |
| EPS (Basic) | $7.91 | $7.57 | $7.39 | $5.82 | $5.05 | $1.46 | $0.98 | $1.27 | $5.86 | $0.48 | $3.15 | $2.78 | |
| EPS (Diluted) | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 | $1.43 | $0.96 | $1.24 | $5.74 | $0.47 | $3.08 | $2.72 | |
| Shares (Basic) | 171,900,000 | 181,300,000 | 183,800,000 | 187,600,000 | 191,400,000 | 191,300,000 | 195,100,000 | 203,700,000 | 217,800,000 | 149,100,000 | 123,000,000 | 128,000,000 | |
| Shares (Diluted) | 173,500,000 | 183,400,000 | 186,300,000 | 190,600,000 | 195,000,000 | 195,000,000 | 199,600,000 | 208,200,000 | 222,600,000 | 152,000,000 | 125,600,000 | 131,100,000 | |
| EBITDA | $3.33B | $3.32B | $3.10B | $2.93B | $2.66B | $2.02B | $1.98B | $1.88B | $1.73B | $931M | $774M | $711M |
Bilanz 28
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.98B | $1.70B | $1.38B | $1.22B | $1.37B | $1.81B | $837M | $891M | $959M | $1.20B | $977M | $867M | |
| Short-term Investments | $161M | $141M | $120M | $93M | $111M | $88M | $62M | $47M | $46M | $40M | · | · | |
| Receivables | $3.40B | $3.20B | $3.38B | $2.92B | $2.55B | $2.41B | $2.58B | $2.39B | $2.10B | $1.71B | $1.17B | $975M | |
| Prepaid Expense | $162M | $154M | $141M | $151M | $156M | $159M | $138M | $151M | $146M | $123M | $51M | $45M | |
| Other Current Assets | · | · | · | · | · | · | · | $322M | $259M | $235M | $83M | $92M | |
| Current Assets | $6.25B | $5.83B | $5.60B | $4.98B | $4.76B | $5.09B | $4.13B | $3.87B | $3.55B | $3.34B | $2.41B | $2.15B | |
| PP&E (Net) | $533M | $535M | $523M | $532M | $497M | $482M | $458M | $434M | $440M | $406M | $188M | $190M | |
| PP&E (Gross) | $1.44B | $1.35B | $1.33B | $1.37B | $1.26B | $1.16B | $1.05B | $1.00B | $923M | $769M | $510M | $496M | |
| Accum. Depreciation | $905M | $819M | $803M | $840M | $765M | $673M | $597M | $567M | $483M | $363M | $322M | $306M | |
| Goodwill | $16.62B | $14.71B | $14.57B | $13.92B | $13.30B | $12.65B | $12.16B | $11.80B | $11.85B | $10.73B | $720M | $464M | |
| Intangibles | $4.96B | $4.50B | $4.84B | $4.82B | $4.94B | $5.21B | $5.51B | $5.95B | $6.59B | $6.39B | $368M | $280M | |
| Total Assets | $29.94B | $26.90B | $26.68B | $25.34B | $24.69B | $24.56B | $23.25B | $22.55B | $22.86B | $21.21B | $3.93B | $3.30B | |
| Accounts Payable | · | · | · | · | · | · | · | $437M | $322M | $250M | $145M | $109M | |
| Accrued Liabilities | $2.97B | $2.95B | $2.85B | $2.67B | $2.36B | $2.23B | $1.94B | $1.86B | $1.66B | $1.49B | $761M | $734M | |
| Current Liabilities | $8.34B | $6.96B | $6.49B | $5.58B | $5.24B | $4.56B | $3.94B | $3.53B | $3.16B | $2.71B | $1.59B | $1.47B | |
| Capital Leases | $225M | $173M | $223M | $264M | $313M | $371M | $396M | · | · | · | $18.0K | $14.0K | |
| Deferred Tax | $179M | $196M | $202M | $464M | $410M | $338M | $646M | $627M | $786M | $2.04B | · | $62M | |
| Other Non-current Liabilities | $688M | $668M | $698M | $671M | $649M | $633M | $456M | $418M | $440M | $402M | $183M | $184M | |
| Total Liabilities | $23.31B | $20.83B | $20.57B | $19.57B | $18.65B | $18.28B | $16.99B | $15.60B | $14.61B | $12.35B | $4.26B | $4.00B | |
| Long-term Debt | $15.72B | $13.98B | $13.67B | $12.75B | $12.12B | $12.53B | $11.64B | $11.01B | $10.27B | $7.22B | $2.50B | $2.31B | |
| Total Debt | $15.72B | $13.98B | $13.67B | $12.75B | $12.12B | $12.53B | $11.64B | $11.01B | $10.22B | $7.20B | $2.47B | $2.29B | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | $144M | |
| Retained Earnings | $7.42B | $6.07B | $4.69B | $3.33B | $2.24B | $1.28B | $998M | $807M | $538M | $-399M | $-462M | $-789M | |
| Treasury Stock | $11.36B | $10.10B | $8.74B | $7.74B | $6.57B | $6.17B | $5.73B | $4.77B | $3.37B | $1.00B | · | · | |
| AOCI | $-943M | $-1.04B | $-867M | $-727M | $-406M | $-205M | $-311M | $-224M | $49M | $-570M | $-111M | $-59M | |
| Stockholders' Equity | $6.50B | $6.07B | $6.11B | $5.76B | $6.04B | $6.28B | $6.26B | $6.71B | $8.00B | $8.63B | $-564M | $-704M | |
| Liabilities + Equity | $29.94B | $26.90B | $26.68B | $25.34B | $24.69B | $24.56B | $23.25B | $22.55B | $22.86B | $21.21B | $3.93B | $3.30B | |
| Shares Outstanding | 169,600,000 | 258,200,000 | 257,200,000 | 256,400,000 | 255,800,000 | 254,700,000 | 253,000,000 | 251,500,000 | 249,500,000 | 248,300,000 | 119,400,000 | 124,100,000 |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.14B | $1.11B | $1.12B | $1.13B | $1.26B | $1.29B | $1.20B | $1.14B | $1.01B | $289M | $128M | $121M | |
| Stock-based Comp | $247M | $206M | $217M | $194M | $170M | $95M | $146M | $113M | $106M | $106M | $38M | $30M | |
| Deferred Tax | $-180M | $-129M | $-269M | $-115M | $-138M | $-176M | $-157M | $-177M | $-1.22B | $115M | $18M | $-6M | |
| Amort. of Intangibles | $984M | $965M | $974M | $970M | $1.12B | $1.15B | $1.07B | $1.02B | $886M | $210M | $67M | $58M | |
| Restructuring | $105M | $67M | $84M | $28M | $20M | $52M | $75M | $68M | $63M | $71M | $30M | $9M | |
| Other Non-cash | $83M | $152M | $-282M | $-40M | $680M | $474M | $35M | $-82M | $-240M | $241M | $-95M | $-69M | |
| Operating Cash Flow | $2.65B | $2.72B | $2.15B | $2.26B | $2.94B | $1.96B | $1.42B | $1.25B | $970M | $860M | $476M | $433M | |
| CapEx | $603M | $602M | $649M | $674M | $640M | $616M | $582M | $459M | $369M | $164M | $78M | $83M | |
| Investing Cash Flow | $-2.31B | $-1.44B | $-1.60B | $-2.01B | $-2.10B | $-796M | $-1.19B | $-810M | $-1.19B | $1.73B | · | · | |
| Stock Repurchased | $1.24B | $1.35B | $992M | $1.17B | $406M | $447M | $949M | $1.41B | $2.62B | $1.10B | $515M | $415M | |
| Net Stock Activity | $-1.24B | $-1.35B | $-992M | $-1.17B | $-406M | $-447M | $-949M | $-1.41B | $-2.62B | $-1.10B | $-515M | $-415M | |
| Financing Cash Flow | $-150M | $-878M | $-382M | $-329M | $-1.24B | $-217M | $-276M | $-452M | $-72M | $-2.28B | · | · | |
| Net Change in Cash | $278M | $326M | $160M | $-150M | $-448M | $977M | $-54M | $-68M | $-239M | $221M | $110M | $90M | |
| Taxes Paid | · | $295M | $340M | $255M | $222M | $209M | $215M | $211M | $195M | $106M | $121M | $139M | |
| Free Cash Flow | $2.05B | $2.11B | $1.50B | $1.59B | $2.30B | $1.34B | $835M | $795M | $601M | $696M | $397M | $349M | |
| Levered FCF | $1.44B | $1.56B | $875M | $1.25B | $1.98B | $1.01B | $535M | $455M | $-777M | $656M | $326M | $420M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.4% | 14.3% | 13.2% | 12.5% | 10.0% | 6.4% | 7.0% | 7.1% | 7.4% | 9.3% | 11.3% | 10.8% | |
| Net Margin | 8.3% | 8.9% | 9.1% | 7.6% | 7.0% | 2.5% | 1.7% | 2.5% | 13.4% | 1.7% | 6.8% | 6.5% | |
| Pretax Margin | 9.8% | 10.8% | 9.7% | 9.5% | 8.1% | 3.3% | 3.2% | 3.1% | 3.4% | 7.0% | 9.4% | 9.2% | |
| EBITDA Margin | 20.4% | 21.5% | 20.7% | 20.3% | 19.1% | 17.8% | 17.8% | 18.1% | 17.8% | 13.5% | 13.5% | 13.0% | |
| ROA | 4.8% | 5.1% | 5.2% | 4.4% | 3.9% | 1.2% | 0.83% | 1.1% | 6.0% | 0.92% | 10.7% | 11.2% | |
| ROE | 21.6% | 22.6% | 22.9% | 18.5% | 15.7% | 4.5% | 3.0% | 3.5% | 15.6% | 2.9% | -61.1% | -52.0% | |
| ROIC | 8.3% | 9.0% | 9.3% | 7.9% | 6.6% | 3.2% | 2.9% | 3.4% | 15.6% | 1.1% | 23.9% | 26.1% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.8 | 0.9 | 0.9 | 0.9 | 1.1 | 1.0 | 1.1 | 1.2 | 1.2 | 1.5 | 1.5 | |
| Quick Ratio | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 1.0 | 1.1 | 1.3 | 1.3 | |
| Debt / Equity | 2.4 | 2.3 | 2.2 | 2.2 | 2.0 | 2.1 | 1.9 | 1.6 | 1.3 | 0.8 | -4.4 | -3.3 | |
| LT Debt / Equity | 2.1 | 2.1 | 2.1 | 2.2 | 2.0 | 2.1 | 1.9 | 1.6 | 1.2 | 0.8 | -4.3 | -3.3 | |
| Interest Coverage | 3.0 | 3.3 | 2.9 | 4.3 | 3.7 | 1.8 | 1.7 | 1.8 | 2.1 | 4.5 | 6.4 | -5.9 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 1.6 | 1.7 | |
| Receivables Turnover | 4.9 | 4.7 | 4.8 | 5.3 | 5.6 | 4.6 | 4.5 | 4.6 | 5.3 | 4.8 | 5.4 | 5.7 |
Wachstumsraten 9
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.9% | 2.8% | 4.0% | 3.9% | 22.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.2% | 3.5% | 9.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4.7% | 2.7% | 27.5% | 15.6% | 246.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 11.1% | 14.8% | 72.1% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 40.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -0.95% | 1.1% | 24.5% | 12.9% | 246.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 7.6% | 12.4% | 69.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 37.3% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16.31B | $15.40B | $14.98B | $14.41B | $13.87B | $11.36B | $11.09B | $10.41B | $9.70B | $6.82B | $5.74B | $5.46B | |
| Net Income TTM | $1.36B | $1.37B | $1.36B | $1.09B | $966M | $279M | $191M | $259M | $1.28B | $72M | $387M | $357M | |
| Market Cap | $38.23B | $34.61B | $42.00B | $38.05B | $53.78B | $34.26B | $29.71B | $29.22B | $24.43B | $18.88B | $8.20B | $7.31B | |
| Enterprise Value | $51.81B | $46.75B | $54.17B | $49.49B | $64.42B | $44.89B | $40.46B | $39.29B | $33.65B | $24.85B | $9.69B | $8.73B | |
| P/E | 28.8 | 26.2 | 31.7 | 35.8 | 57.0 | 125.3 | 160.9 | 93.7 | 17.1 | 161.8 | 22.3 | 21.6 | |
| P/S | 2.3 | 2.2 | 2.8 | 2.6 | 3.9 | 3.0 | 2.7 | 2.8 | 2.5 | 2.8 | 1.4 | 1.3 | |
| P/B | 5.9 | 5.7 | 6.9 | 6.6 | 8.9 | 5.7 | 4.9 | 4.4 | 3.0 | 2.2 | -14.5 | -10.4 | |
| P / Cash Flow | 14.4 | 12.7 | 19.5 | 16.8 | 18.3 | 17.5 | 21.0 | 23.3 | 25.2 | 22.0 | 17.2 | 16.9 | |
| P / FCF | 18.6 | 16.4 | 28.0 | 24.0 | 23.4 | 25.5 | 35.6 | 36.8 | 40.6 | 27.1 | 20.6 | 20.9 | |
| EV / EBITDA | 15.6 | 14.1 | 17.5 | 16.9 | 24.2 | 22.2 | 20.4 | 20.9 | 19.4 | 26.7 | 12.5 | 12.3 | |
| EV / FCF | 25.3 | 22.1 | 36.1 | 31.2 | 28.0 | 33.4 | 48.5 | 49.4 | 56.0 | 35.7 | 24.4 | 25.0 | |
| EV / Revenue | 3.2 | 3.0 | 3.6 | 3.4 | 4.6 | 4.0 | 3.6 | 3.8 | 3.5 | 3.6 | 1.7 | 1.6 | |
| Earnings Yield | 3.5% | 3.8% | 3.1% | 2.8% | 1.8% | 0.80% | 0.62% | 1.1% | 5.9% | 0.62% | 4.5% | 4.6% |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.37B | $4.15B | $4.36B | $4.10B | $4.02B | $3.83B | $3.96B | $3.90B | $3.81B | $3.74B | $3.87B | $3.74B | $3.73B | $3.65B | $3.74B | $3.56B | |
| Gross Profit | · | · | · | · | · | · | · | $915M | $863M | $827M | · | $862M | $850M | $802M | · | $812M | |
| SG&A Expense | $574M | $502M | $468M | $514M | $509M | $508M | $453M | $522M | $509M | $508M | $556M | $502M | $482M | $513M | $583M | $517M | |
| Operating Income | $506M | $514M | $627M | $553M | $506M | $496M | $626M | $550M | $520M | $506M | $501M | $481M | $524M | $471M | $379M | $472M | |
| Interest Expense | $197M | $192M | $193M | $189M | $182M | $165M | $171M | $170M | $163M | $166M | $181M | $181M | $169M | $141M | $128M | $108M | |
| Interest Income | $7M | $10M | $11M | $13M | $10M | $11M | $11M | $13M | $12M | $11M | $12M | $14M | $4M | $6M | $6M | $4M | |
| Other Non-op | $-12M | $-4M | $94M | $31M | $-11M | $-15M | $78M | $-44M | $67M | $-11M | $47M | $35M | $16M | $26M | $18M | $-8M | |
| Pretax Income | $301M | $328M | $537M | $408M | $323M | $323M | $544M | $349M | $436M | $340M | $373M | $349M | $375M | $362M | $275M | $360M | |
| Income Tax | $60M | $59M | $59M | $76M | $56M | $61M | $112M | $65M | $75M | $49M | $-102M | $51M | $81M | $71M | $48M | $70M | |
| Net Income | $256M | $274M | $514M | $331M | $266M | $249M | $437M | $285M | $363M | $288M | $469M | $303M | $297M | $289M | $227M | $283M | |
| EPS (Basic) | $1.54 | $1.63 | $3.00 | $1.94 | $1.55 | $1.42 | $2.43 | $1.57 | $1.99 | $1.58 | $2.56 | $1.66 | $1.61 | $1.56 | $1.23 | $1.52 | |
| EPS (Diluted) | $1.53 | $1.61 | $2.97 | $1.93 | $1.54 | $1.40 | $2.41 | $1.55 | $1.97 | $1.56 | $2.54 | $1.63 | $1.59 | $1.53 | $1.21 | $1.49 | |
| Shares (Basic) | 166,100,000 | 168,400,000 | -345,800,000 | 170,200,000 | 171,800,000 | 175,700,000 | -364,900,000 | 182,100,000 | 182,200,000 | 181,900,000 | -369,300,000 | 182,900,000 | 184,400,000 | 185,800,000 | -377,200,000 | 186,500,000 | |
| Shares (Diluted) | 167,300,000 | 169,800,000 | -348,800,000 | 171,700,000 | 173,200,000 | 177,400,000 | -369,400,000 | 184,200,000 | 184,300,000 | 184,300,000 | -374,500,000 | 185,500,000 | 186,700,000 | 188,600,000 | -383,300,000 | 189,400,000 | |
| EBITDA | $798M | $802M | · | $839M | $782M | $761M | · | $828M | $789M | $770M | · | $778M | $783M | $724M | · | $720M |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.91B | $1.95B | $1.98B | $1.81B | $2.04B | $1.74B | $1.70B | $1.57B | $1.54B | $1.44B | · | $1.22B | $1.38B | $1.49B | · | $1.27B | |
| Short-term Investments | $171M | $156M | $161M | $158M | $149M | $136M | $141M | $140M | $133M | $131M | · | $108M | $110M | $104M | · | $87M | |
| Receivables | $3.35B | $3.35B | $3.40B | $3.27B | $3.34B | $3.27B | $3.20B | $3.20B | $3.25B | $3.43B | · | $3.23B | $3.14B | $3.06B | · | $2.64B | |
| Prepaid Expense | $220M | $167M | $162M | $177M | $200M | $166M | $154M | $195M | $191M | $173M | · | $177M | $179M | $165M | · | $176M | |
| Current Assets | $6.23B | $6.22B | $6.25B | $5.98B | $6.34B | $5.91B | $5.83B | $5.63B | $5.62B | $5.65B | · | $5.21B | $5.33B | $5.33B | · | $4.75B | |
| PP&E (Net) | $547M | $516M | $533M | $525M | $536M | $533M | $535M | $513M | $503M | $513M | · | $498M | $510M | $520M | · | $507M | |
| PP&E (Gross) | · | · | $1.44B | · | · | · | $1.35B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $905M | · | · | · | $819M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $16.60B | $16.54B | $16.62B | $15.95B | $15.61B | $15.03B | $14.71B | $15.09B | $14.48B | $14.52B | $14.57B | $14.29B | $14.18B | $14.02B | $13.92B | $13.18B | |
| Intangibles | $4.75B | $4.80B | $4.96B | $4.71B | $4.60B | $4.50B | $4.50B | $4.73B | $4.61B | $4.72B | · | $4.91B | $4.94B | $4.76B | · | $4.72B | |
| Total Assets | $29.88B | $29.68B | $29.94B | $28.73B | $28.63B | $27.32B | $26.90B | $27.18B | $26.40B | $26.57B | · | $25.98B | $26.04B | $25.74B | · | $24.22B | |
| Accrued Liabilities | · | · | $2.97B | · | · | · | $2.95B | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $8.81B | $8.33B | $8.34B | $8.51B | $7.57B | $7.18B | $6.96B | $6.99B | $6.62B | $6.45B | · | $6.59B | $6.54B | $6.66B | · | $5.25B | |
| Capital Leases | $242M | $232M | $225M | $233M | $210M | $177M | $173M | $188M | $192M | $204M | · | $217M | $242M | $255M | · | $259M | |
| Deferred Tax | $173M | $159M | $179M | $207M | $216M | $197M | $196M | $128M | $149M | $164M | · | $365M | $367M | $421M | · | $560M | |
| Other Non-current Liabilities | $645M | $617M | $688M | $698M | $671M | $676M | $668M | $612M | $632M | $595M | · | $679M | $703M | $641M | · | $561M | |
| Total Liabilities | $23.58B | $23.33B | $23.31B | $22.44B | $22.85B | $21.34B | $20.83B | $20.21B | $19.68B | $20.23B | · | $20.17B | $20.29B | $19.81B | · | $18.88B | |
| Long-term Debt | $16.00B | $15.83B | $15.72B | $14.96B | $15.49B | $14.33B | $13.98B | $13.51B | $13.26B | $13.54B | · | $13.63B | $13.78B | $13.18B | · | $12.39B | |
| Total Debt | $16.00B | $15.83B | · | $14.96B | $15.49B | $14.33B | · | $13.51B | $13.26B | $13.54B | · | $13.63B | $13.78B | $13.18B | · | $12.39B | |
| Retained Earnings | $7.96B | $7.70B | $7.42B | $6.91B | $6.58B | $6.31B | $6.07B | $5.63B | $5.34B | $4.98B | · | $4.22B | $3.92B | $3.62B | · | $3.11B | |
| Treasury Stock | $12.32B | $11.91B | $11.36B | $11.14B | $11.14B | $10.53B | $10.10B | $8.94B | $8.74B | $8.74B | · | $8.51B | $8.36B | $7.87B | · | $7.71B | |
| AOCI | $-964M | $-968M | $-943M | $-928M | $-882M | $-978M | $-1.04B | $-826M | $-949M | $-911M | · | $-903M | $-760M | $-731M | · | $-898M | |
| Stockholders' Equity | $6.17B | $6.22B | $6.50B | $6.16B | $5.78B | $5.98B | $6.07B | $6.97B | $6.71B | $6.34B | · | $5.80B | $5.75B | $5.93B | $5.76B | $5.35B | |
| Liabilities + Equity | $29.88B | $29.68B | $29.94B | $28.73B | $28.63B | $27.32B | $26.90B | $27.18B | $26.40B | $26.57B | · | $25.98B | $26.04B | $25.74B | · | $24.22B | |
| Shares Outstanding | 164,600,000 | 166,900,000 | 169,600,000 | 170,300,000 | 170,000,000 | 174,100,000 | 176,100,000 | 181,600,000 | 182,300,000 | 182,200,000 | 257,200,000 | 182,500,000 | 183,100,000 | 185,500,000 | 256,400,000 | 185,800,000 |
Cashflow 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $292M | $288M | $317M | $286M | $276M | $265M | $303M | $278M | $269M | $264M | $316M | $297M | $259M | $253M | $357M | $248M | |
| Stock-based Comp | $95M | $65M | $60M | $55M | $60M | $72M | $48M | $54M | $48M | $56M | $45M | $47M | $50M | $75M | $58M | $61M | |
| Deferred Tax | $-36M | $-38M | $-48M | $-46M | $-45M | $-41M | $-15M | $-34M | $-14M | $-66M | $-152M | $-47M | $-43M | $-27M | $-63M | $-24M | |
| Restructuring | $63M | $51M | $24M | $20M | $32M | $29M | $-4M | $28M | $28M | $15M | $17M | $30M | $20M | $17M | $13M | $4M | |
| Other Non-cash | · | $29M | · | · | · | $23M | · | · | · | $-20M | · | · | · | $-173M | · | · | |
| Operating Cash Flow | $558M | $618M | $735M | $908M | $443M | $568M | $885M | $721M | $588M | $522M | $747M | $583M | $402M | $417M | $560M | $863M | |
| CapEx | $198M | $127M | $174M | $136M | $151M | $142M | $164M | $150M | $143M | $145M | $179M | $146M | $160M | $164M | $171M | $165M | |
| Investing Cash Flow | $-381M | $-196M | $-1.10B | $-550M | $-346M | $-305M | $-310M | $-599M | $-221M | $-314M | $-212M | $-573M | $-596M | $-222M | $-477M | $-717M | |
| Stock Repurchased | $398M | $552M | $212M | $0 | $657M | $375M | $1.15B | $200M | $0 | $0 | $229M | $144M | $490M | $129M | $65M | $210M | |
| Net Stock Activity | · | $-552M | · | · | · | $-375M | · | · | · | $0 | · | · | · | $-129M | · | · | |
| Financing Cash Flow | $-214M | $-433M | $535M | $-572M | $145M | $-258M | $-375M | $-137M | $-260M | $-106M | $-420M | $-144M | $95M | $87M | $-193M | $-251M | |
| Net Change in Cash | $-38M | $-33M | $166M | $-225M | $299M | $38M | $130M | $27M | $101M | $68M | $152M | $-158M | $-112M | $278M | $-58M | $-154M | |
| Free Cash Flow | · | $491M | · | · | · | $426M | · | · | · | $377M | · | · | · | $253M | · | · | |
| Levered FCF | · | $334M | · | · | · | $292M | · | · | · | $235M | · | · | · | $140M | · | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 23.5% | 22.6% | 22.1% | · | 23.1% | 22.8% | 22.0% | · | 22.8% | |
| Operating Margin | 11.6% | 12.4% | · | 13.5% | 12.6% | 13.0% | · | 14.1% | 13.6% | 13.5% | · | 12.9% | 14.1% | 12.9% | · | 13.2% | |
| Net Margin | 5.9% | 6.6% | · | 8.1% | 6.6% | 6.5% | · | 7.3% | 9.5% | 7.7% | · | 8.1% | 8.0% | 7.9% | · | 7.9% | |
| Pretax Margin | 6.9% | 7.9% | · | 10.0% | 8.0% | 8.4% | · | 9.0% | 11.4% | 9.1% | · | 9.3% | 10.1% | 9.9% | · | 10.1% | |
| EBITDA Margin | 18.3% | 19.3% | · | 20.5% | 19.5% | 19.9% | · | 21.2% | 20.7% | 20.6% | · | 20.8% | 21.0% | 19.8% | · | 20.2% | |
| ROA | 0.88% | 0.96% | · | 1.2% | 0.97% | 0.92% | · | 1.1% | 1.4% | 1.1% | · | 1.2% | 1.2% | 1.1% | · | 1.2% | |
| ROE | 4.3% | 4.5% | · | 5.0% | 4.3% | 4.0% | · | 4.5% | 5.8% | 4.7% | · | 5.4% | 5.3% | 4.9% | · | 5.1% | |
| ROIC | 1.8% | 1.9% | · | 2.1% | 2.0% | 2.0% | · | 2.2% | 2.2% | 2.2% | · | 2.1% | 2.1% | 2.0% | · | 2.1% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.7 | · | 0.7 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | |
| Quick Ratio | 0.6 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.8 | |
| Debt / Equity | 2.6 | 2.5 | · | 2.4 | 2.7 | 2.4 | · | 1.9 | 2.0 | 2.1 | · | 2.3 | 2.4 | 2.2 | · | 2.3 | |
| LT Debt / Equity | 2.2 | 2.2 | · | 2.1 | 2.5 | 2.2 | · | 1.8 | 1.8 | 2.0 | · | 2.1 | 2.2 | 2.0 | · | 2.3 | |
| Interest Coverage | 2.6 | 2.7 | · | 2.9 | 2.8 | 3.0 | · | 3.2 | 3.2 | 3.0 | · | 2.7 | 3.1 | 3.3 | · | 4.4 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.4 |
Bewertung (TTM) 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16.64B | $16.10B | · | $15.84B | $15.56B | $15.28B | · | $15.18B | $15.02B | $14.85B | · | $14.68B | $14.48B | $14.32B | · | $14.06B | |
| Net Income TTM | $1.13B | $1.12B | · | $1.13B | $1.16B | $1.19B | · | $1.24B | $1.25B | $1.18B | · | $1.17B | $1.12B | $1.15B | · | $1.12B | |
| Market Cap | $31.80B | $28.46B | · | $32.35B | $26.79B | $30.69B | · | $43.03B | $38.55B | $46.08B | · | $35.91B | $41.16B | $36.89B | · | $33.66B | |
| Enterprise Value | $45.72B | $42.19B | · | $45.33B | $40.09B | $43.15B | · | $54.83B | $50.13B | $58.04B | · | $48.21B | $53.44B | $48.47B | · | $44.69B | |
| P/E | 29.2 | 26.3 | · | 29.6 | 24.4 | 27.2 | · | 35.3 | 31.3 | 40.1 | · | 31.5 | 37.8 | 32.9 | · | 31.0 | |
| P/S | 1.9 | 1.8 | · | 2.0 | 1.7 | 2.0 | · | 2.8 | 2.6 | 3.1 | · | 2.4 | 2.8 | 2.6 | · | 2.4 | |
| P/B | 5.2 | 4.6 | · | 5.3 | 4.6 | 5.1 | · | 6.2 | 5.7 | 7.3 | · | 6.2 | 7.2 | 6.2 | · | 6.3 | |
| P / Cash Flow | · | 46.1 | · | · | · | 54.0 | · | · | · | 88.3 | · | · | · | 88.5 | · | · | |
| P / FCF | · | 58.0 | · | · | · | 72.1 | · | · | · | 122.2 | · | · | · | 145.8 | · | · | |
| EV / EBITDA | 57.3 | 52.6 | · | 54.0 | 51.3 | 56.7 | · | 66.2 | 63.5 | 75.4 | · | 62.0 | 68.3 | 67.0 | · | 62.1 | |
| EV / FCF | · | 85.9 | · | · | · | 101.3 | · | · | · | 153.9 | · | · | · | 191.6 | · | · | |
| EV / Revenue | 2.7 | 2.6 | · | 2.9 | 2.6 | 2.8 | · | 3.6 | 3.3 | 3.9 | · | 3.3 | 3.7 | 3.4 | · | 3.2 | |
| Earnings Yield | 3.4% | 3.8% | · | 3.4% | 4.1% | 3.7% | · | 2.8% | 3.2% | 2.5% | · | 3.2% | 2.6% | 3.0% | · | 3.2% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $16.31B | $15.40B | $14.98B | $14.41B | $13.87B |
| Betriebsgewinnmarge % | 13.4% | 14.3% | 13.2% | 12.5% | 10.0% |
| Nettoergebnis | $1.36B | $1.37B | $1.36B | $1.09B | $966M |
| Verwässerte EPS | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 2.4 | 2.3 | 2.2 | 2.2 | 2.0 |
| Liquiditätsgrad | 0.7 | 0.8 | 0.9 | 0.9 | 0.9 |
| Quick Ratio | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $2.05B | $2.11B | $1.50B | $1.59B | $2.30B |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 1.176 Einreicher · $16.9B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 132 (-13 vs. Vorquartal) | 103 (-63 vs. Vorquartal) | 389 (-15 vs. Vorquartal) | 420 (+23 vs. Vorquartal) | -3.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2.107.074.341 | 10.905.053 | 12,50% | Aktien |
| STATE STREET CORP | $1.450.742.906 | 7.508.244 | 8,61% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.449.535.087 | 7.501.993 | 8,60% | Aktien |
| Artisan Partners Limited Partnership | $916.526.317 | 4.743.434 | 5,44% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $751.515.288 | 3.907.352 | 4,46% | Aktien |
| NORGES BANK | $437.632.480 | 2.264.944 | 2,60% | Aktien |
| Longview Partners (Guernsey) LTD | $289.976.847 | 1.500.760 | 1,72% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $282.111.725 | 1.460.055 | 1,67% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $280.214.615 | 1.643.102 | 1,66% | Aktien |
| LYRICAL ASSET MANAGEMENT LP | $243.436.719 | 1.259.894 | 1,44% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $241.535.241 | 1.250.053 | 1,43% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $240.910.560 | 1.246.820 | 1,43% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $204.721.978 | 1.059.526 | 1,21% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $188.339.728 | 974.742 | 1,12% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $181.113.608 | 937.344 | 1,07% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $160.725.420 | 831.826 | 0,95% | Aktien |
| CADIAN CAPITAL MANAGEMENT, LP | $157.619.601 | 815.752 | 0,94% | Aktien |
| FIL Ltd | $153.554.253 | 794.712 | 0,91% | Aktien |
| JARISLOWSKY, FRASER Ltd | $149.227.880 | 785.658 | 0,89% | Aktien |
| GREENHAVEN ASSOCIATES INC | $148.401.655 | 768.045 | 0,88% | Aktien |
| 1832 Asset Management L.P. | $143.802.826 | 744.244 | 0,85% | Aktien |
| AMERIPRISE FINANCIAL INC | $142.211.800 | 735.972 | 0,84% | Aktien |
| FMR LLC | $135.375.060 | 700.627 | 0,80% | Aktien |
| Balyasny Asset Management L.P. | $135.333.607 | 700.412 | 0,80% | Aktien |
| Boston Partners | $133.444.690 | 690.636 | 0,79% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $121.523.014 | 628.936 | 0,72% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $113.104.610 | 585.374 | 0,67% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $106.359.117 | 550.456 | 0,63% | Aktien |
| EARNEST PARTNERS LLC | $105.901.563 | 548.088 | 0,63% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $99.841.411 | 516.724 | 0,59% | Aktien |
| Swiss National Bank | $92.490.550 | 478.680 | 0,55% | Aktien |
| BlackRock, Inc. | $91.938.713 | 475.824 | 0,55% | Aktien |
| CIBC Bancorp USA Inc. | $91.205.076 | 471.352 | 0,54% | Aktien |
| D. E. Shaw & Co., Inc. | $90.085.733 | 466.234 | 0,53% | Aktien |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $79.369.559 | 410.773 | 0,47% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $78.508.764 | 406.318 | 0,47% | Aktien |
| National Pension Service | $72.645.503 | 375.973 | 0,43% | Aktien |
| Ilex Capital Partners (UK) LLP | $71.680.176 | 370.977 | 0,43% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $70.949.418 | 367.195 | 0,42% | Aktien |
| California Public Employees Retirement System | $70.656.690 | 365.680 | 0,42% | Aktien |
| Vanguard Global Advisers, LLC | $69.529.444 | 359.846 | 0,41% | Aktien |
| Quantinno Capital Management LP | $69.138.831 | 357.824 | 0,41% | Aktien |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $68.883.914 | 356.505 | 0,41% | Aktien |
| Legal & General Group Plc | $67.679.555 | 350.272 | 0,40% | Aktien |
| Assenagon Asset Management S.A. | $65.786.773 | 340.476 | 0,39% | Aktien |
| CI INVESTMENTS INC. | $65.379.079 | 338.366 | 0,39% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $64.474.036 | 333.682 | 0,38% | Aktien |
| RHUMBLINE ADVISERS | $64.175.589 | 332.138 | 0,38% | Aktien |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $61.424.638 | 317.900 | 0,36% | Aktien |
| Capital World Investors | $61.228.906 | 316.887 | 0,36% | Aktien |
| FIRST MANHATTAN CO. LLC. | $60.389.365 | 312.542 | 0,36% | Aktien |
| Man Group plc | $57.113.707 | 295.589 | 0,34% | Aktien |
| Cornerstone Investment Partners, LLC | $56.162.291 | 290.665 | 0,33% | Aktien |
| Point72 Asset Management, L.P. | $53.998.807 | 279.468 | 0,32% | Aktien |
| Qube Research & Technologies Ltd | $53.924.997 | 279.086 | 0,32% | Aktien |
| Vulcan Value Partners, LLC | $50.209.376 | 259.856 | 0,30% | Aktien |
| GOLDMAN SACHS GROUP INC | $47.369.345 | 245.158 | 0,28% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $44.584.443 | 261.431 | 0,26% | Aktien |
| Danica Pension, Livsforsikringsaktieselskab | $43.968.177 | 227.555 | 0,26% | Aktien |
| SEB Asset Management AB | $41.578.752 | 215.189 | 0,25% | Aktien |
| COUNTRY TRUST BANK | $41.040.701 | 212.404 | 0,24% | Aktien |
| BANK OF AMERICA CORP /DE/ | $40.135.272 | 207.718 | 0,24% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $39.462.000 | 204.232 | 0,23% | Aktien |
| Associated Banc-Corp | $38.755.873 | 200.579 | 0,23% | Aktien |
| Freestone Grove Partners LP | $38.705.830 | 200.320 | 0,23% | Aktien |
| ASSETMARK, INC | $38.066.693 | 197.012 | 0,23% | Aktien |
| Trajan Wealth LLC | $35.265.548 | 182.515 | 0,21% | Aktien |
| Robeco Institutional Asset Management B.V. | $33.903.348 | 175.465 | 0,20% | Aktien |
| HARRIS ASSOCIATES L P | $33.507.826 | 173.418 | 0,20% | Aktien |
| UBS Group AG | $32.389.275 | 167.629 | 0,19% | Aktien |
| Dana Investment Advisors, Inc. | $32.065.825 | 165.955 | 0,19% | Aktien |
| Woodline Partners LP | $31.980.808 | 165.515 | 0,19% | Aktien |
| KENSICO CAPITAL MANAGEMENT CORP | $31.881.300 | 165.000 | 0,19% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $30.940.319 | 160.130 | 0,18% | Aktien |
| BARCLAYS PLC | $30.871.145 | 159.772 | 0,18% | Aktien |
| Act Two Investors LLC | $30.672.902 | 158.746 | 0,18% | Aktien |
| AVIVA PLC | $29.357.847 | 151.940 | 0,17% | Aktien |
| MML INVESTORS SERVICES, LLC | $28.789.342 | 148.998 | 0,17% | Aktien |
| Meridiem Capital Partners LP | $27.945.409 | 144.630 | 0,17% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $27.653.453 | 143.119 | 0,16% | Aktien |
| Gotham Asset Management, LLC | $27.184.508 | 140.692 | 0,16% | Aktien |
| LPL Financial LLC | $26.931.587 | 139.383 | 0,16% | Aktien |
| Candriam S.C.A. | $26.917.640 | 139.445 | 0,16% | Aktien |
| CIBC Asset Management Inc | $26.395.011 | 136.606 | 0,16% | Aktien |
| Howard Capital Management Group, LLC | $26.033.014 | 134.733 | 0,15% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $25.336.358 | 131.127 | 0,15% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $24.914.763 | 128.620 | 0,15% | Aktien |
| Banco Santander, S.A. | $23.956.575 | 123.986 | 0,14% | Aktien |
| MORGAN STANLEY | $23.730.050 | 122.813 | 0,14% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $23.514.874 | 121.700 | 0,14% | Verkaufsoption |
| TUDOR INVESTMENT CORP ET AL | $23.098.292 | 119.544 | 0,14% | Aktien |
| Compagnie Lombard Odier SCmA | $22.951.639 | 118.785 | 0,14% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $22.870.437 | 134.106 | 0,14% | Aktien |
| Cetera Investment Advisers | $22.677.210 | 117.365 | 0,13% | Aktien |
| Artemis Investment Management LLP | $22.412.167 | 115.993 | 0,13% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $22.184.748 | 114.816 | 0,13% | Aktien |
| VAN ECK ASSOCIATES CORP | $21.593.301 | 111.755 | 0,13% | Aktien |
| Andra AP-fonden | $20.704.409 | 121.405 | 0,12% | Aktien |
| GDS Wealth Management | $20.556.096 | 106.387 | 0,12% | Aktien |
| Parkman Healthcare Partners LLC | $20.444.801 | 105.811 | 0,12% | Aktien |
Unternehmensinsider 31 Insider · 14 Führungskräfte · 16 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ari Bousbib | Chairman, Chief Executive Officer & President Power of Attorney | 29. Juli 2026 M | 835.941 | 0 | 10 | $-38.553.192 |
| Michael R. Mcdonnell | EVP and CFO | 3. Oktober 2016 A | 44.106 | 0 | 0 | $0 |
| Richard W Staub | President, Research & Development Solutions Power of Attorney | 3. August 2026 S | 13.312 | 0 | 1 | $-1.279.740 |
| Bhavik Patel | President, MedTech and Consumer Health Power of Attorney | 31. Juli 2026 S | 1.348 | 0 | 1 | $-436.426 |
| John D Ratliff | President and COO | 18. November 2013 X | 0 | 0 | 0 | $0 |
| Kevin K Gordon | EVP and COO | 9. Juni 2016 X | 17.899 | 0 | 0 | $0 |
| Keriann Cherofsky | SVP, Corporate Controller Power of Attorney | 29. Juli 2026 S | 2.989 | 0 | 1 | $-136.827 |
| Eric Sherbet | Executive Vice President, General Counsel Power of Attorney | 29. Juli 2026 S | 20.999 | 0 | 1 | $-1.245.800 |
| Iii James H Erlinger | Exec VP and GC | 3. Oktober 2016 A | 18.024 | 0 | 0 | $0 |
| Thomas Pike | Vice Chair, Pres R&D Solutions | 3. Oktober 2016 A | 185.460 | 0 | 0 | $0 |
| Kevin C Knightly | Pres Info & Tech Solutions | 3. Oktober 2016 A | 26.826 | 0 | 0 | $0 |
| Charles Edward Williams | Sr VP and Controller | 3. März 2016 A | 3.911 | 0 | 0 | $0 |
| Derek M. Winstanly | Exec VP & Chief Cust & Gov Ofc | 13. Februar 2014 X | 229.500 | 0 | 0 | $0 |
| Michael I. Mortimer | Exec VP & Chief Admin Officer | 18. November 2013 S | 25.000 | 0 | 0 | $0 |
| Morris Leslie Wims | Direktor | 14. Juli 2026 A | — | 0 | 0 | $0 |
| Jim Fasano | Direktor | 14. Juli 2026 A | — | 0 | 0 | $0 |
| Colleen A Goggins | Direktor | 14. Juli 2026 A | — | 0 | 0 | $0 |
| John G Danhakl | Direktor | 14. Juli 2026 A | 0 | 0 | 0 | $0 |
| John Connaughton | Direktor | 2. Dezember 2021 G | 0 | 0 | 0 | $0 |
| Dennis B Ph D Gillings | Direktor | 28. August 2017 S | 84.067 | 0 | 0 | $0 |
| Ronald A Rittenmeyer | Direktor | 3. Oktober 2016 A | 54.849 | 0 | 0 | $0 |
| Annie H. Lo | Direktor | 12. Mai 2016 P | 2.062 | 0 | 0 | $0 |
| John M. Leonard | Direktor | 5. Mai 2016 A | 2.316 | 0 | 0 | $0 |
| Michael J Evanisko | Direktor | 5. Mai 2016 A | 5.346 | 0 | 0 | $0 |
| Jack M Greenberg | Direktor | 5. Mai 2016 A | 2.930 | 0 | 0 | $0 |
| Leonard D Schaeffer | Direktor | 5. Mai 2016 A | 65.896 | 0 | 0 | $0 |
| Christopher R Gordon | Direktor | 5. August 2015 S | 9.944.017 | 0 | 0 | $0 |
| Mireille Gillings | Direktor | 19. Mai 2015 X | 11.663.929 | 0 | 0 | $0 |
| Canada Pension Plan Investment Board | 10%-Eigentümer | 18. September 2018 J | 1.569.600 | 0 | 0 | $0 |
| DENNIS & MIREILLE GILLINGS FOUNDATION | 10%-Eigentümer | 19. Mai 2015 S | 103.556 | 0 | 0 | $0 |
| Gillings Limited Partnership | 10%-Eigentümer | 10. November 2014 S | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Canada Pension Plan Investment Board, CPP Investment Board Private Holdings Inc. ×8 Einreichungen | 13. August 2019 | — | Erste Einreichung | — | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., TPG Advisors VI, Inc., TPG Advisors V, Inc., TPG Biotech Advisors, Inc., David Bonderman, James G. Coulter ×9 Einreichungen | 12. März 2019 | — | Erste Einreichung | Kapitalstruktur | SEC |
| Quintiles Transnational Holdings Inc. | 13. Mai 2016 | — | Erste Einreichung | M&A / Verkauf | SEC |
| OR | 13. Mai 2016 | — | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 177 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| EKG · First Trust Exchange-Traded Fund II | 8,26% | 1.204 NS | 30. Juni 2026 | N-PORT |
| HEAL · Global X Funds | 4,72% | 6.483 NS | 31. Mai 2026 | N-PORT |
| BSJQ · Invesco Exchange-Traded Self-Indexe… | 3,06% | 24.615.000 | 21. August 2026 | Täglich |
| RSPH · Invesco Exchange-Traded Fund Trust | 2,04% | 65.208 SH | 21. August 2026 | Täglich |
| FLV · AMERICAN CENTURY ETF TRUST | 1,91% | 37.019 NS | 31. Mai 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1,89% | 13.621 SH | 21. August 2026 | Täglich |
| RUNN · Strategic Trust | 1,75% | 33.257 NS | 31. Mai 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,73% | 5.832 NS | 30. April 2026 | N-PORT |
| EPMB · Harbor ETF Trust | 1,57% | 447 NS | 30. April 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,36% | 380 NS | 30. April 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,03% | 726 NS | 30. April 2026 | N-PORT |
| LRGC · AB Active ETFs, Inc. | 0,89% | 60.947 NS | 31. Mai 2026 | N-PORT |
| NUMV · Nushares ETF Trust | 0,83% | 22.672 NS | 30. April 2026 | N-PORT |
| THMZ · Lazard Active ETF Trust | 0,82% | 2.293 NS | 30. Juni 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,80% | 44.382 NS | 30. April 2026 | N-PORT |
| RFFC · ALPS ETF Trust | 0,75% | 1.218 NS | 31. Mai 2026 | N-PORT |
| IYH · iShares Trust | 0,66% | 99.195 SH | 21. August 2026 | Täglich |
| COWZ · Pacer Funds Trust | 0,62% | 709.284 NS | 30. April 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0,62% | 1.821 NS | 30. April 2026 | N-PORT |
| IMCV · iShares Trust | 0,58% | 26.899 SH | 21. August 2026 | Täglich |
| VOE · VANGUARD INDEX FUNDS | 0,56% | 1.072.113 SH | 19. August 2026 | Täglich |
| ITAN · EA Series Trust | 0,55% | 2.710 NS | 29. Mai 2026 | N-PORT |
| IXJ · iShares Trust | 0,52% | 87.943 SH | 21. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,48% | 510.171 SH | 19. August 2026 | Täglich |
| RXL · ProShares Trust | 0,45% | 1.768 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,44% | 78.509 NS | 30. April 2026 | N-PORT |
| IWS · iShares Trust | 0,41% | 250.393 SH | 21. August 2026 | Täglich |
| REVS · Columbia ETF Trust I | 0,40% | 7.214 NS | 30. April 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,39% | 3.383 NS | 30. April 2026 | N-PORT |
| EVUS · iShares Trust | 0,36% | 5.323 SH | 21. August 2026 | Täglich |
| SUSA · iShares Trust | 0,32% | 50.767 SH | 21. August 2026 | Täglich |
| CVMC · Morgan Stanley ETF Trust | 0,31% | 1.653 NS | 30. Juni 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,31% | 3.616.975 SH | 19. August 2026 | Täglich |
| IWR · iShares Trust | 0,30% | 677.410 SH | 21. August 2026 | Täglich |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,30% | 8.582.000 | 21. August 2026 | Täglich |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,29% | 6.499 NS | 31. Mai 2026 | N-PORT |
| IMCB · iShares Trust | 0,29% | 19.156 SH | 21. August 2026 | Täglich |
| SIZE · iShares Trust | 0,27% | 4.598 SH | 21. August 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,26% | 1.025.042 SH | 21. August 2026 | Täglich |
| EUSA · iShares, Inc. | 0,26% | 19.768 SH | 21. August 2026 | Täglich |
| DFVE · DoubleLine ETF Trust | 0,25% | 411 NS | 30. Juni 2026 | N-PORT |
| XOEF · iShares Trust | 0,23% | 209 SH | 21. August 2026 | Täglich |
| PY · Principal Exchange-Traded Funds | 0,23% | 2.572 NS | 30. Juni 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,22% | 81 NS | 31. Mai 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,21% | 79.706 NS | 30. April 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,21% | 72.385 NS | 30. April 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,20% | 19.216 NS | 31. Mai 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 4.875 NS | 30. April 2026 | N-PORT |
| USXF · iShares Trust | 0,17% | 9.914 SH | 21. August 2026 | Täglich |
| OALC · Unified Series Trust | 0,16% | 2.166 NS | 31. Mai 2026 | N-PORT |